Public procurement notice: Contract Notice
Published: 2019-02-12
Buyer: Ministry of Defence, C&C, C&C
Country: UK
Contract type: Services
Procedure: Restricted procedure
CPV classification: 34152000
Estimated value: 600000 GBP
Submission deadline: 2019-03-11
Award criteria: The most economic tender

Technical requirements: Contract for the Provision of Augmented/Mixed-Reality CBRN Simulation Trainer for Defence Medical Services
The Ministry of Defence requires an augmented- or mixed-reality simulation trainer set-up that enables high-fidelity simulation of a variety of chemical agent poisonings, for high impact training of medical professionals.
We require an augmented- or mixed-reality simulation trainer set-up that enables high-fidelity simulation of a variety of chemical agent poisonings, for high impact training of medical professionals.
Currently CBRN clinical training is delivered on an inert plastic manikin, in full CBRN protection kit, with realistic kit surrounding, and used in, the scenarios. We are looking to increase the fidelity of this simulation by using augmented — or mixed-reality. Initial plans include (but proposals should not be limited to) overlaying characteristic signs and symptoms of chemical agent poisoning onto the face, neck and chest of the plastic manikin, blurring the participants vision if they fail to carry out proper precautions, and adding several pieces of static virtual equipment into the surround.
These signs/symptoms/effects would be controlled from a computer, by the training faculty, in a simple and user-friendly manner.
General considerations of the solution we are looking for is that it is, user-friendly, inter-operable (using readily available commercial-off-the-shelf hardware), allows at least 2 subjects to be involved in the task and to verbally and physically interact with one another and standard physical medical equipment. It will be situated in a hard-standing hangar.
The provider of this solution would need to be willing to travel down to the location of the training (situated within the Salisbury area) for an initial planning meeting, set-up, and to resolve any significant problems that may have arose. They would also ideally need to have, or at least be willing to obtain, UK security clearance.
Phase 1: of the contract would fund a pilot study. This would involve creating the simulator set-up detailed above, with just 2 clinical scenarios (in the same setting). This would be then tested on members of the CBRN clinicians course (dates TBC), and the results reported to the JFC innovation board.
Phase 2: of the contract would fund the further development of this model, to include 7 scenarios (but still just at one location, in one setting), make any improvements informed by the pilot, and support the project (troubleshooting any issues) over a period of 2 years from start of phase 2.
The provider must be aware of our requirement that this capability must be built with potential to scale – both to be replicated, and built upon for other clinical training scenarios. Submissions should make note of ability for MoD to autonomously replicate the system, buy further equipment and replicate the set-up in another location.
Initial response should be a paper-based explanation of the suggested training solution – this should include a one-page description, ideally accompanied by videos of previous similar solutions that the bidder has previously completed as part of their portfolio.
An initial downselect of submissions will take place on the week of the 11th March, respondents will be notified of whether they are invited to tender on 15th March, at which point they will be provided with a statement of requirement. From this they will be asked to provide confirmation they can adhere to it, and a quote of the “no greater than” costings, by 15th April.
The successful bidder will then be awarded a contract to undertake development of the pilot study, which, if successful (a judgement made by the JFC innovation committee in a date tbc Autumn 2019), will result in awarding of a contract extension to deliver the full roll-out detailed briefly above. Companies that have not been selected are in no way restricted from pursuing different markets with their product design.
Phase 1: of the contract would fund a pilot study. This would involve creating the simulator set-up detailed above, with just 2 clinical scenarios (in the same setting). This would be then tested on members of the CBRN clinicians course (dates TBC), and the results reported to the JFC innovation board. This is a period of approximately 6 months (firm contract period)
Phase 2: of the contract would fund the further development of this model, to include 7 scenarios (but still just at one location, in one setting), make any improvements informed by the pilot, and support the project (troubleshooting any issues) over a period of 2 years from start of phase 2, subject to approval from the JFC Innovation Board.


Award value: 600000